Rare variants in the neurotrophin signaling pathway implicated in schizophrenia risk

Schizophr Res. 2015 Oct;168(1-2):421-8. doi: 10.1016/j.schres.2015.07.002. Epub 2015 Jul 26.

Abstract

Multiple lines of evidence corroborate impaired signaling pathways as relevant to the underpinnings of schizophrenia. There has been an interest in neurotrophins, since they are crucial mediators of neurodevelopment and in synaptic connectivity in the adult brain. Neurotrophins and their receptors demonstrate aberrant expression patterns in cortical areas for schizophrenia cases in comparison to control subjects. There is little known about the contribution of neurotrophin genes in psychiatric disorders. To begin to address this issue, we conducted high-coverage targeted exome capture in a subset of neurotrophin genes in 48 comprehensively characterized cases with schizophrenia-related psychosis. We herein report rare missense polymorphisms and novel missense mutations in neurotrophin receptor signaling pathway genes. Furthermore, we observed that several genes have a higher propensity to harbor missense coding variants than others. Based on this initial analysis we suggest that rare variants and missense mutations in neurotrophin genes might represent genetic contributions involved across psychiatric disorders.

Keywords: ARMS; De novo; Exome sequencing; Kidins220; Neurotrophin; Rare variant; Schizophrenia; Sporadic.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Analysis of Variance
  • Depression / etiology
  • Female
  • Humans
  • Intelligence / genetics
  • Male
  • Middle Aged
  • Models, Molecular
  • Nerve Growth Factors / genetics*
  • Nerve Growth Factors / metabolism
  • Polymorphism, Genetic / genetics*
  • Psychiatric Status Rating Scales
  • Schizophrenia / complications
  • Schizophrenia / pathology*
  • Signal Transduction / genetics*
  • Young Adult

Substances

  • Nerve Growth Factors